Ping C. Sun

Department Of Otolaryngology Head And Neck Surgery, Jinan 250022, 
Jinan, CN 
Department Of Otolaryngology Head And Neck Surgery, Jinan 250022, 
Jinan, CN 

Overview

Ping Sun practices practicing medicine in Jinan, China.

Their clinical expertise encompasses Metastatic Pleural Tumor, Gastroesophageal Junction Cancer, Ear Cancer, Breast Cancer, and Splenectomy.

They are actively involved in clinical research, co-authoring 64 peer reviewed articles and participating in 3 clinical trials.

Locations

Department Of Otolaryngology Head And Neck Surgery, Jinan 250022, Jinan, 250022, China
Other Locations
Yantai, 264100, China
China Japan Union Hospital Of Jilin University, Jilin Provincial Key Laboratory Of Translational Medicine In Surgery, Changchun, China
Yantai, 264000, China
China
Shengli, China
Weihai, China
P.R. China, Zibo, 255200, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
EMBER-3: A Phase 3, Randomized, Open-Label Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Patients With Estrogen Receptor Positive, HER2 Negative Locally Advanced or Metastatic Breast Cancer Previously Treated With Endocrine Therapy
Enrollment Status: Active_not_recruiting
Publish Date: July 22, 2026
Intervention Type: Drug
Study Drugs: Imlunestrant, Exemestane, Fulvestrant, Abemaciclib
Study Phase: Phase 3
Multicenter, Open-label, Phase II Study With a Safety Lead-in Part Investigating the Efficacy, Safety and Pharmacokinetics of Encorafenib and Binimetinib Combination in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer Who Are BRAF- and MEK Inhibitor Treatment-naïve
Multicenter, Open-label, Phase II Study With a Safety Lead-in Part Investigating the Efficacy, Safety and Pharmacokinetics of Encorafenib and Binimetinib Combination in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer Who Are BRAF- and MEK Inhibitor Treatment-naïve
Enrollment Status: Active_not_recruiting
Publish Date: May 01, 2026
Intervention Type: Drug
Study Drugs: Encorafenib, Binimetinib
Study Phase: Phase 2
A Randomized, Open-label, Active-controlled, Multicenter Phase 3 Study to Investigate the Efficacy and Safety of Roxadustat for Treatment of Anemia in Subjects Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
A Randomized, Open-label, Active-controlled, Multicenter Phase 3 Study to Investigate the Efficacy and Safety of Roxadustat for Treatment of Anemia in Subjects Receiving Chemotherapy Treatment for Non-Myeloid Malignancies
Enrollment Status: Completed
Publish Date: June 06, 2023
Intervention Type: Drug
Study Phase: Phase 3
View 2 Less Clinical Trials

64 Total Publications

Clinical characteristics and surgical management of primary intralabyrinthine tumor
Clinical characteristics and surgical management of primary intralabyrinthine tumor
Journal: Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery
Published: December 22, 2025

Frequently Asked Questions about Ping C. Sun

Is Ping C. Sun a top-rated expert for Metastatic Pleural Tumor?

MediFind is an objective health platform that identifies experts based on real-world data. Ping C. Sun is classified as an Experienced expert for Metastatic Pleural Tumor, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Ping C. Sun participate in research or clinical trials?

Yes. Ping C. Sun has published 64 articles and abstracts on conditions like Metastatic Pleural Tumor. You can view a list of Ping C. Sun's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Sun's expertise for a condition
ConditionClose
        View All 22 Experienced Conditions
        Want to save this expert for later?
        Sign Up
        Not sure about your diagnosis?
        Check Your Symptoms
         
         
         
         
        Learn about our expert tiers
        Learn More
        Are you the provider on this profile?
        Claim Profile